Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of PD-L1 expression with driver gene mutations and clinicopathological characteristics in non-small cell lung cancer: A real-world study of 10 441 patients.
Ruiz G, Enrico D, Mahmoud YD, Ruiz A, Cantarella MF, Leguina L, Barberis M, Beña A, Brest E, Starapoli S, Mendoza Bertelli A, Tsou F, Pupareli C, Coppola MP, Scocimarro A, Sena S, Levit P, Perfetti A, Aman E, Girotti MR, Arrieta O, Martín C, Salanova R. Ruiz G, et al. Among authors: girotti mr. Thorac Cancer. 2024 Apr;15(11):895-905. doi: 10.1111/1759-7714.15244. Epub 2024 Mar 8. Thorac Cancer. 2024. PMID: 38456253 Free PMC article.
Clinical and Urodynamic results of the Argus T® sling in moderate and severe male stress urinary incontinence after radical prostatectomy - a 5 year prospective study.
Carvalho AP, Silva AB, Lebani BR, Pinto ER, Felipe MR, Skaf M, Girotti ME, Zequi SC, Sacomani CAR, Almeida FG. Carvalho AP, et al. Among authors: girotti me. Int Braz J Urol. 2023 Jul-Aug;49(4):452-461. doi: 10.1590/S1677-5538.IBJU.2023.0003. Int Braz J Urol. 2023. PMID: 37171826 Free PMC article.
Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report.
Enrico D, Tsou F, Catani G, Pupareli C, Girotti MR, Ulloa Alvarez DE, Waisberg F, Rodríguez A, Reyes R, Chacón M, Reguart N, Martín C. Enrico D, et al. Among authors: girotti mr. JTO Clin Res Rep. 2022 Dec 28;4(2):100456. doi: 10.1016/j.jtocrr.2022.100456. eCollection 2023 Feb. JTO Clin Res Rep. 2022. PMID: 36798785 Free PMC article.
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology.
Bannoud N, Stupirski JC, Cagnoni AJ, Hockl PF, Pérez Sáez JM, García PA, Mahmoud YD, Gambarte Tudela J, Scheidegger MA, Marshall A, Corrie PG, Middleton MR, Mariño KV, Girotti MR, Croci DO, Rabinovich GA. Bannoud N, et al. Among authors: girotti mr. Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2214350120. doi: 10.1073/pnas.2214350120. Epub 2023 Jan 12. Proc Natl Acad Sci U S A. 2023. PMID: 36634146 Free PMC article. Clinical Trial.
Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2.
Narváez D, Waisberg F, Soulé T, Angel M, Bruno L, Girotti MR, Pupareli C, Chacón M, Petracci FE. Narváez D, et al. Among authors: girotti mr. Ecancermedicalscience. 2022 Sep 26;16:1448. doi: 10.3332/ecancer.2022.1448. eCollection 2022. Ecancermedicalscience. 2022. PMID: 36405946 Free PMC article.
223 results